German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron : Rashtra News This will limit treatment options for Omicron-induced COVID-19, said researchers. (Representational)Frankfurt: German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely
people out of the hospital and you target the high risk populations. make sure they have access to high quality masks and treatments. one blunders of the cdc is they over-estimated how much omicron was. there they pulled back on the supply of monoclonal antibodies. they were not sending it out to hospitals because they said it won t work against omicron. delta is more prevalent and we don t have access to monoclonal antibodieses for those patients. they need to get their act together. they are costing lives. pete: colonel, the marine corp kicking people out for not getting vaccines. what does that tell you about the institution? i served for 9 years.
make sure they have access to high qualitye masks and treatments. one blunders of the cdc is they over-estimated how much omicron was. there they pulled back on the supply of monoclonal antibodies. they were not sending it out to hospitals because they said it won t work against omicron. delta is more prevalent and we don t have access to monoclonal antibodies forlo those patients. they need to get their act together. they are costing lives. pete: colonel, the marine corp kicking people out for not getting vaccines. what does that tell you about